1. Home
  2. SHO vs COLL Comparison

SHO vs COLL Comparison

Compare SHO & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SHO

Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

HOLD

Current Price

$9.19

Market Cap

1.8B

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$45.25

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHO
COLL
Founded
1995
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
SHO
COLL
Price
$9.19
$45.25
Analyst Decision
Hold
Strong Buy
Analyst Count
8
6
Target Price
$9.31
$47.50
AVG Volume (30 Days)
1.7M
467.2K
Earning Date
02-20-2026
11-06-2025
Dividend Yield
4.03%
N/A
EPS Growth
N/A
N/A
EPS
0.01
1.63
Revenue
$937,930,000.00
$757,067,000.00
Revenue This Year
$5.61
$26.35
Revenue Next Year
$5.58
$3.67
P/E Ratio
$931.93
$28.49
Revenue Growth
3.04
26.34
52 Week Low
$7.45
$23.23
52 Week High
$12.27
$50.79

Technical Indicators

Market Signals
Indicator
SHO
COLL
Relative Strength Index (RSI) 52.18 39.60
Support Level $9.00 $48.50
Resistance Level $9.16 $50.79
Average True Range (ATR) 0.15 1.27
MACD -0.00 -0.68
Stochastic Oscillator 70.53 3.32

Price Performance

Historical Comparison
SHO
COLL

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in Califiornia which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its hotel ownership segment.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: